InvestorsHub Logo
Replies to #291 on Depomed (DEPO)

porgyrusty

03/04/13 1:50 PM

#294 RE: surf1944 #291

Here comes the pain!!!

surf1944

03/04/13 1:58 PM

#295 RE: surf1944 #291

March 4, 2013
13:57 EDT DEPO Depomed retreats after FDA panel votes against approving drug
Subscribe for More Information
13:54 EDT DEPO Depomed resumes trading, down 9.8% after FDA advisors vote against drug approval
13:38 EDT DEPO Depomed says will cease all spending related to Sefelsa following FDA meeting
Subscribe for More Information
13:37 EDT DEPO Depomed to resume trading at 13:50 ET
Quotes resume at 13:45 ET.
13:33 EDT DEPO Depomed provides update on Sefelsa FDA advisory committee
Subscribe for More Information
12:44 EDT DEPO Depomed's proposed menopause treatment rejected by FDA panel, WSJ says
Subscribe for More Information
11:40 EDT DEPO FDA panel says Depomed menopause drug ineffective, DJ reports
Subscribe for More Information
07:41 EDT DEPO FDA's Reproductive Health Drugs Advisory Committee to hold a meeting
The Committee discusses Depomed's New Drug Application for Serada(r). Serada is Depomed's proprietary extended release formulation of Gabapentin in development for treatment of menopausal hot flashes. The meeting is being held at FDA offices in Silver Spring, Maryland on March 4 at 8 am. Webcast Link
07:01 EDT DEPO Depomed trading halted, news pending
Subscribe for More Information